{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:10:41Z","timestamp":1795108241187,"version":"4.10.3"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["ZYGD23031"],"award-info":[{"award-number":["ZYGD23031"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2023NSFSC1618"],"award-info":[{"award-number":["2023NSFSC1618"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2026NSFSC0576"],"award-info":[{"award-number":["2026NSFSC0576"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.aohep.2026.102221","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T23:13:12Z","timestamp":1778368392000},"page":"102221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predictors of recompensation in immunosuppressive therapy for biopsy-proven autoimmune hepatitis patients with decompensated cirrhosis"],"prefix":"10.1016","volume":"31","author":[{"given":"Yujie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoting","family":"Men","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunke","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Ao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.aohep.2026.102221_bib0001","doi-asserted-by":"crossref","first-page":"185","DOI":"10.32074\/1591-951X-241","article-title":"Pathology of autoimmune hepatitis","volume":"113","author":"Covelli","year":"2021","journal-title":"Pathologica"},{"issue":"2","key":"10.1016\/j.aohep.2026.102221_bib0002","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41423-021-00768-8","article-title":"Autoimmune hepatitis","volume":"19","author":"Terziroli Beretta-Piccoli","year":"2022","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10.1016\/j.aohep.2026.102221_bib0003","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome","volume":"42","author":"Feld","year":"2005","journal-title":"Hepatol (Baltim Md)"},{"issue":"7","key":"10.1016\/j.aohep.2026.102221_bib0004","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1053\/j.gastro.2011.02.065","article-title":"Long-term outcomes of patients with autoimmune hepatitis managed at a nontransplant center","volume":"140","author":"Hoeroldt","year":"2011","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.aohep.2026.102221_bib0005","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2026.102221_bib0006","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12072-021-10170-1","article-title":"Harada K,et al. The Asian pacific association for the study of the liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis","volume":"15","author":"Wang","year":"2021","journal-title":"Hepatol Int"},{"issue":"2","key":"10.1016\/j.aohep.2026.102221_bib0007","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune Hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.aohep.2026.102221_bib0008","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1016\/j.jhep.2024.05.005","article-title":"Need for risk stratification in treatment of patients with autoimmune hepatitis","volume":"81","author":"Yang","year":"2024","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2026.102221_bib0009","doi-asserted-by":"crossref","first-page":"101497","DOI":"10.1016\/j.aohep.2024.101497","article-title":"Clinical, biochemical and histological features related to treatment response and prognosis in autoimmune hepatitis","volume":"29","author":"Guedes","year":"2024","journal-title":"Ann Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2026.102221_bib0010","first-page":"366","article-title":"Characteristics of initial diagnosis in autoimmune liver disease: an 18-year, retrospective single-center study","volume":"58","author":"Li YN, Zhou L, Zhang J, Wang Y, Wang XY, Guo LP","year":"2019","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"3","key":"10.1016\/j.aohep.2026.102221_bib0011","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16116","article-title":"The prevalence of acute and decompensated cirrhotic autoimmune Hepatitis is increasing","volume":"45","author":"Peng","year":"2025","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2026.102221_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2024.101233","article-title":"Mechanisms and implications of recompensation in cirrhosis","author":"Piano","year":"2024","journal-title":"JHEP Rep"},{"issue":"11","key":"10.1016\/j.aohep.2026.102221_bib0013","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/tri.13008","article-title":"Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study","volume":"30","author":"Aravinthan","year":"2017","journal-title":"Transpl Int"},{"issue":"3","key":"10.1016\/j.aohep.2026.102221_bib0014","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1053\/gast.1996.v111.pm8780575","article-title":"Bordato J,et al. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study","volume":"111","author":"Vorobioff","year":"1996","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.aohep.2026.102221_bib0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/apt.16658","article-title":"Seo YS,et al. Determinants of re-compensation in patients with hepatitis B virus-related decompensated cirrhosis starting antiviral therapy","volume":"55","author":"Kim","year":"2022","journal-title":"Aliment Pharm Ther"},{"key":"10.1016\/j.aohep.2026.102221_bib0016","doi-asserted-by":"crossref","unstructured":"El-Sherif O, Jiang ZG, Tapper EB, Huang KC, Zhong A, Osinusi A,et al. Baseline factors associated with improvements in decompensated cirrhosis after direct-acting antiviral therapy for Hepatitis C Virus infection. Gastroenterology 2018;154(8):2111\u20132121. https:\/\/doi.org\/10.1053\/j.gastro.2018.03.022.e8.","DOI":"10.1053\/j.gastro.2018.03.022"},{"issue":"4","key":"10.1016\/j.aohep.2026.102221_bib0017","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII Faculty. Baveno VII \u2013 Renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.aohep.2026.102221_bib0018","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1111\/liv.15676","article-title":"Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol-related cirrhosis","volume":"43","author":"Hofer","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2026.102221_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2022.07.037","article-title":"Validation of Baveno VII criteria for recompensation in entecavir-treated patients with hepatitis B-related decompensated cirrhosis","volume":"77","author":"Wang","year":"2022","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.aohep.2026.102221_bib0020","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1007\/s12072-023-10579-w","article-title":"Recompensation in treatment-na\u00efve HBV-related decompensated cirrhosis: a 5-year multi-center observational study comparing patients with ascites and bleeding","volume":"17","author":"He","year":"2023","journal-title":"Hepatol Int"},{"issue":"8","key":"10.1016\/j.aohep.2026.102221_bib0021","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/apt.17908","article-title":"Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis","volume":"59","author":"Hofer","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aohep.2026.102221_bib0022","article-title":"Prevalence and clinical outcomes of recompensation in decompensated cirrhosis: a systematic review and meta-analysis","author":"Goh","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.aohep.2026.102221_bib0023","doi-asserted-by":"crossref","first-page":"101496","DOI":"10.1016\/j.jhepr.2025.101496","article-title":"Recompensation in patients with autoimmune hepatitis-related decompensated cirrhosis following immunosuppressive therapy","volume":"7","author":"Chen","year":"2025","journal-title":"JHEP Rep"},{"key":"10.1016\/j.aohep.2026.102221_bib0024","first-page":"1965492","article-title":"Yang L.Efficacy and safety of immunosuppressive therapy for PBC-AIH overlap syndrome accompanied by decompensated cirrhosis: a real-world study","author":"Fan","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.aohep.2026.102221_bib0025","first-page":"3389","article-title":"Secoemestrin C inhibits activation of NKT\/conventional T cells and protects against concanavalin A-induced autoimmune hepatitis in mice","volume":"12","author":"Tan","year":"2020","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.aohep.2026.102221_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108411","article-title":"Pathogenesis of Concanavalin A induced autoimmune hepatitis in mice","volume":"102","author":"Hao","year":"2022","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.aohep.2026.102221_bib0027","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/j.jhep.2023.06.010","article-title":"Dysregulation of the LPC-ATX-LPA axis in autoimmune hepatitis is associated with monocyte activation","volume":"80","author":"Yang","year":"2024","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2026.102221_bib0028","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41419-019-2217-6","article-title":"Critical roles of conventional dendritic cells in autoimmune hepatitis via autophagy regulation","volume":"11","author":"Fan","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.aohep.2026.102221_bib0029","doi-asserted-by":"crossref","first-page":"726128","DOI":"10.3389\/fphar.2021.726128","article-title":"Glucose metabolism reprogramming of regulatory T cells in concanavalin A-induced Hepatitis","volume":"12","author":"Huang","year":"2021","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.aohep.2026.102221_bib0030","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1097\/HEP.0000000000001089","article-title":"Efficacy and safety of infliximab in patients with autoimmune hepatitis","volume":"81","author":"Efe","year":"2025","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.aohep.2026.102221_bib0031","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2026.102221_bib0032","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2023.04.021","article-title":"EASL clinical practice guidelines on acute-on-chronic liver failure","volume":"79","year":"2023","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2026.102221_bib0033","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/hep.510240314","article-title":"Ultrasonographic determination of ascitic volume","volume":"24","author":"Inadomi","year":"1996","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.aohep.2026.102221_bib0034","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jhep.2022.06.001","article-title":"EASL clinical practice guidelines on the management of hepatic encephalopathy","volume":"77","year":"2022","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2026.102221_bib0035","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jhep.2021.12.041","article-title":"Hirschfield GM,et al. Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis group","volume":"76","author":"Pape","year":"2022","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.aohep.2026.102221_bib0036","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12072-017-9808-z","article-title":"New concepts on the clinical course and stratification of compensated and decompensated cirrhosis","volume":"12","author":"D\u2019Amico","year":"2018","journal-title":"Hepatol Int"},{"issue":"3","key":"10.1016\/j.aohep.2026.102221_bib0037","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/HEP.0000000000000589","article-title":"Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: first report of the IAIHG retrospective registry","volume":"79","author":"Slooter","year":"2024","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.aohep.2026.102221_bib0038","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/apt.15571","article-title":"Review article: malnutrition\/sarcopenia and frailty in patients with cirrhosis","volume":"51","author":"Bunchorntavakul","year":"2020","journal-title":"Aliment Pharm Ther"},{"issue":"4","key":"10.1016\/j.aohep.2026.102221_bib0039","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jhep.2024.05.020","article-title":"Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis","volume":"81","author":"Di Cola","year":"2024","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2026.102221_bib0040","doi-asserted-by":"crossref","first-page":"311","DOI":"10.51821\/85.2.9016","article-title":"Malnutrition is highly prevalent in hospitalized cirrhotic patients and associates with a poor outcome","volume":"85","author":"Dumont","year":"2022","journal-title":"Acta Gastroenterol Belg"},{"issue":"2","key":"10.1016\/j.aohep.2026.102221_bib0041","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/archinte.1991.00400020036008","article-title":"Alanine aminotransferase in clinical practice. A review","volume":"151","author":"Sherman","year":"1991","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.aohep.2026.102221_bib0042","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12072-015-9665-6","article-title":"Albumin in chronic liver disease: structure, functions and therapeutic implications","volume":"10","author":"Spinella","year":"2016","journal-title":"Hepatol Int"},{"issue":"4","key":"10.1016\/j.aohep.2026.102221_bib0043","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jceh.2014.08.007","article-title":"Zaccherini G.Role of human albumin in the management of complications of liver cirrhosis","volume":"4","author":"Bernardi","year":"2014","journal-title":"J Clin Exp Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2026.102221_bib0044","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/apt.70188","article-title":"Diabetes mellitus in patients with autoimmune Hepatitis: frequency, risk factors and effect on outcome","volume":"62","author":"Flatley","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.aohep.2026.102221_bib0045","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s12072-024-10727-w","article-title":"Ding Y, et al. Liver fibrosis is closely linked with metabolic-associated diseases in patients with autoimmune hepatitis","volume":"18","author":"Liu","year":"2024","journal-title":"Hepatol Int"},{"issue":"12","key":"10.1016\/j.aohep.2026.102221_bib0046","first-page":"1038","article-title":"Guidelines on the diagnosis and management of autoimmune hepatitis (2021)","volume":"60","year":"2021","journal-title":"Chin J Intern Med"},{"issue":"3","key":"10.1016\/j.aohep.2026.102221_bib0047","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12016-016-8583-2","article-title":"The management of autoimmune Hepatitis patients with decompensated cirrhosis: real-world experience and a comprehensive review","volume":"52","author":"Wang","year":"2017","journal-title":"Clin Rev Allerg Immu"},{"key":"10.1016\/j.aohep.2026.102221_bib0048","doi-asserted-by":"crossref","unstructured":"Slooter CD, Troyer IDM, van den Brand FF, de Vries R, Heymans MW, Heneghan MA, et al. Early prognostic factors for reduced survival in autoimmune Hepatitis: a systematic review with meta-analysis. Clin Gastroenterol Hepatol 2025. https:\/\/doi.org\/10.1016\/j.cgh.2025.04.034. Published online July 23S1542-3565(25)00618-4.","DOI":"10.1016\/j.cgh.2025.04.034"},{"key":"10.1016\/j.aohep.2026.102221_bib0049","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3389\/fphar.2019.00346","article-title":"NUDT15 polymorphism confer increased susceptibility to thiopurine-induced leukopenia in patients with autoimmune hepatitis and related cirrhosis","volume":"10","author":"Fan","year":"2019","journal-title":"Front Pharmacol"},{"issue":"11","key":"10.1016\/j.aohep.2026.102221_bib0050","first-page":"3213","article-title":"Pachter HL,et al. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha","volume":"119","author":"Connolly","year":"2009","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.aohep.2026.102221_bib0051","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.molimm.2014.10.021","article-title":"Synergistic effect of pro-inflammatory tnf\u03b1 and IL-17 in periostin mediated collagen deposition: potential role in liver fibrosis","volume":"64","author":"Amara","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.aohep.2026.102221_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113683","article-title":"Role of interferon-gamma (IFN-\u03b3) and IFN-\u03b3 receptor 1\/2 (IFN\u03b3R1\/2) in regulation of immunity, infection, and cancer development: iFN-\u03b3-dependent or independent pathway","volume":"155","author":"Ding","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.aohep.2026.102221_bib0053","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/hep.26746","article-title":"IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice","volume":"59","author":"Harley","year":"2014","journal-title":"Hepatology"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268126000426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268126000426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:41:46Z","timestamp":1787949706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268126000426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1665268126000426"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2026.102221","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of recompensation in immunosuppressive therapy for biopsy-proven autoimmune hepatitis patients with decompensated cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2026.102221","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102221"}}